India-based clinical-stage medical diagnostics company RNT Health Insights has received breakthrough device designation (BDD) from the US Food and Drug Administration (FDA) for its early gastric cancer detection tool.

During routine endoscopy procedures, this technology is designed to detect in real-time any lesions found in the upper gastrointestinal tract indicative of early gastric cancer, as well as gastric malignancy, including gastric atrophy, nodules, polyps, masses and growths present in the stomach.

Gastric cancer ranks as the fourth most deadly cancer worldwide, with a five-year survival rate below 40%.

Early detection is crucial, as it can significantly increase the survival rate to 90%.

Traditional endoscopic methods for diagnosing gastric cancer have a variable miss rate of 4.6%-25.8%, influenced by the endoscopist’s experience and visual assessment.

The early gastric cancer detection tool developed by RNT Health Insights is claimed to have a 96% accuracy rate, as demonstrated in preclinical validation.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The FDA BDD is granted to medical devices that come with reasonable clinical proof to provide major advancements representing breakthrough technology in either diagnosis or treatment of life-threatening or irreversibly debilitating diseases or conditions, with approved alternatives currently not available, and therefore their availability is in the interest of patients.

This BDD will facilitate a faster review process, potentially expediting the availability of this technology to healthcare providers and patients.

Established in 2022, RNT Health Insights is focused on incorporating advanced technology into real-time diagnostic procedures in endoscopy.

The company’s flagship project targets the early detection of gastric pathologies, using a vast collection of endoscopic images and videos to refine diagnostic precision and enhance patient care.